Skip to main content
Elekta logo

Elekta — Investor Relations & Filings

Ticker · EKTA ISIN · SE0000163628 LEI · 54930044O54BK617EP80 ST Manufacturing
Filings indexed 1,124 across all filing types
Latest filing 2012-06-05 Interim / Quarterly Rep…
Country SE Sweden
Listing ST EKTA

Elekta is a company specializing in precision radiation medicine. It develops and provides clinical solutions, including equipment and software, for treating cancer and brain disorders. The company's portfolio features linear accelerators, the Elekta Unity MR-Linac system, Leksell Gamma Knife for stereotactic radiosurgery, and comprehensive brachytherapy solutions. Elekta also offers oncology informatics software to support treatment planning and clinical workflow. A key focus is advancing adaptive radiotherapy, a personalized approach that utilizes real-time imaging to precisely target tumors and minimize exposure to healthy tissue, aiming to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive year-end financial report for Elekta for the fiscal year 2011/12. It contains detailed financial statements, including order bookings, net sales, operating results, net income, cash flow, and earnings per share, along with management commentary and regional market analysis. Since it covers a full fiscal year and provides substantive financial data and analysis, it is classified as an Interim/Quarterly Report (IR) in the context of this taxonomy, as it serves as the primary financial disclosure for the period. FY 2012
2012-06-05 English
Elekta announces changes to its Executive Management
Board/Management Information Classification · 1% confidence The document is explicitly titled 'Elekta announces changes to its Executive Management' and details appointments, departures, and the resulting composition of the 'Executive Management' team. This directly aligns with the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2012-06-05 English
Förändringar i Elektas koncernledning
Board/Management Information Classification · 1% confidence The document is titled "Förändringar i Elektas koncernledning" (Changes in Elekta's Group Management) and is explicitly labeled as a "Pressmeddelande" (Press Release). The content details appointments, departures, and the resulting composition of the senior management team. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2012-06-05 Swedish
Number of outstanding shares in Elekta AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short press release announcing a change in the number of outstanding shares due to the exercise of employee options. It explicitly states the new total number of shares and the breakdown between A and B shares as of May 31, 2012. This directly relates to changes in the company's capital structure via share issuance. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not an earnings release (ER), a dividend notice (DIV), or a transaction in own shares (POS), as POS typically refers to repurchases or sales, whereas this is an issuance via option exercise, which falls under the broader capital change category (SHA). Given the specific nature of the announcement, SHA is the most accurate classification.
2012-05-31 English
Antalet utestående aktier i Elekta AB (publ)
Share Issue/Capital Change Classification · 1% confidence The document is a short press release dated May 31, 2012, titled 'Antalet utestående aktier i Elekta AB (publ)' (The number of outstanding shares in Elekta AB (publ)). It explicitly states that new B-shares were issued due to the exercise of employee stock options, resulting in a change to the total number of outstanding shares (95,298,190). This directly relates to a change in the company's capital structure via share issuance. This aligns best with the 'Share Issue/Capital Change' definition (SHA). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a transaction in own shares (POS) as it details the result of option exercises leading to new shares.
2012-05-31 Swedish
US Oncology Network väljer Elektas onkologiinformationssystem MOSAIQ som standard
Regulatory Filings Classification · 1% confidence The document is titled 'Pressmeddelande' (Press Release) and announces a significant business agreement between US Oncology Network and Elekta regarding the adoption of the MOSAIQ OIS system and the purchase of Elekta Infinity systems. It includes quotes from executives, details about the order booking period (Q3 FY 2011/12), contact information for Corporate Communications and Investor Relations, and boilerplate information about both companies. This format strongly indicates a general business announcement or news release, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a press release announcing a business event, and it doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Dividend (DIV), the most appropriate general category for a non-standard, non-financial-specific announcement is Regulatory Filings (RNS), which serves as a broad category for official company announcements not covered elsewhere, or potentially a general Investor Relations document. Given the context of a press release detailing a contract win, RNS is the best fit as a general regulatory/public announcement fallback.
2012-05-24 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.